Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 228

1.

Safeguarding against substandard/counterfeit drugs: mitigating a macroeconomic pandemic.

Wertheimer AI, Norris J.

Res Social Adm Pharm. 2009 Mar;5(1):4-16. doi: 10.1016/j.sapharm.2008.05.002.

PMID:
19285285
3.

Pharmaceutical counterfeiting.

Deisingh AK.

Analyst. 2005 Mar;130(3):271-9. Epub 2004 Dec 14. Review.

PMID:
15724152
4.
6.

Counterfeit drugs: defining the problem and finding solutions.

Wertheimer AI, Santella TM.

Expert Opin Drug Saf. 2005 Jul;4(4):619-22.

PMID:
16011440
7.

Pilot study of essential drug quality in two major cities in India.

Bate R, Tren R, Mooney L, Hess K, Mitra B, Debroy B, Attaran A.

PLoS One. 2009 Jun 23;4(6):e6003. doi: 10.1371/journal.pone.0006003.

8.

Substandard medicines in resource-poor settings: a problem that can no longer be ignored.

Caudron JM, Ford N, Henkens M, Macé C, Kiddle-Monroe R, Pinel J.

Trop Med Int Health. 2008 Aug;13(8):1062-72. doi: 10.1111/j.1365-3156.2008.02106.x. Epub 2008 Jul 8. Review.

9.

[Counterfeit drugs in Israel and worldwide. Part I: the extent of occurrence and impending threats].

Tamir O, Friedman N, Furman-Assaf S, Marom E, Arieli M, Shemer J.

Harefuah. 2010 Jul;149(7):466-9, 479. Hebrew.

PMID:
21465763
10.

[Counterfeit drugs in Israel and worldwide. Part II: distribution profile and anti-counterfeiting strategies and actions].

Furman-Assaf S, Tamir O, Marom E, Arieli M, Shemer J.

Harefuah. 2010 Jul;149(7):470-5, 479. Hebrew.

PMID:
21465764
11.

[Quality of medicines in least developed countries].

Videau JY.

Med Trop (Mars). 2006 Dec;66(6):533-7. French.

PMID:
17286015
12.

Counterfeit and substandard antimalarial drugs in Cambodia.

Lon CT, Tsuyuoka R, Phanouvong S, Nivanna N, Socheat D, Sokhan C, Blum N, Christophel EM, Smine A.

Trans R Soc Trop Med Hyg. 2006 Nov;100(11):1019-24. Epub 2006 Jun 12.

PMID:
16765399
13.

Counterfeit pharmaceuticals: current status and future projections.

Wertheimer AI, Chaney NM, Santella T.

J Am Pharm Assoc (2003). 2003 Nov-Dec;43(6):710-7; quiz 717-8.

PMID:
14717268
14.

Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence.

Kelesidis T, Kelesidis I, Rafailidis PI, Falagas ME.

J Antimicrob Chemother. 2007 Aug;60(2):214-36. Epub 2007 Jun 5. Review.

PMID:
17550892
15.

[Counterfeit medicines: a growing threat].

Barbereau S.

Med Trop (Mars). 2006 Dec;66(6):529-32. French.

PMID:
17286014
16.

Substandard and counterfeit medicines.

Rassool GH.

J Adv Nurs. 2004 May;46(3):338-9. No abstract available.

PMID:
15119344
17.

Deterring the importation of counterfeit pharmaceutical products.

Stearn DW.

Food Drug Law J. 2004;59(4):537-61. No abstract available.

PMID:
15875351
18.

[Update on counterfeit drugs: a growing risk for public health].

Juillet Y.

Bull Acad Natl Med. 2008 Oct;192(7):1423-34; discussion 1434-6. Review. French.

PMID:
19445366
19.

Drugs, drugs--who has the drugs?

Blair J.

J Healthc Prot Manage. 2012;28(1):28-32.

PMID:
22423518
20.

New countermeasures considered as drug counterfeiting grows.

Schubert C.

Nat Med. 2008 Jul;14(7):700. doi: 10.1038/nm0708-700a. No abstract available.

PMID:
18607355

Supplemental Content

Support Center